+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Total Iron Binding Capacity Test"

2024 North America Immunoassay Analyzers and Reagents - USA, Canada, Mexico - Supplier Shares and Competitive Analysis, 2023-2028 - Product Thumbnail Image

2024 North America Immunoassay Analyzers and Reagents - USA, Canada, Mexico - Supplier Shares and Competitive Analysis, 2023-2028

  • Report
  • February 2024
  • Canada, Mexico, North America Canada, Mexico, North America
From
From
From
From
From
From
From
From
From
From
From
From
From
From
2024 Dominican Republic Immunoassay Analyzers and Reagents - Supplier Shares and Competitive Analysis, 2023-2028 - Product Thumbnail Image

2024 Dominican Republic Immunoassay Analyzers and Reagents - Supplier Shares and Competitive Analysis, 2023-2028

  • Report
  • February 2024
  • Dominica, Dominican Republic Dominica, Dominican Republic
From
From
Loading Indicator

The Total Iron Binding Capacity (TIBC) Test is a diagnostic test used to measure the amount of transferrin, a protein that binds to iron, in the blood. It is used to diagnose iron deficiency anemia, a condition in which the body does not have enough iron to produce healthy red blood cells. The TIBC test is also used to monitor the effectiveness of iron supplementation and to diagnose other conditions such as liver disease and hemochromatosis. The TIBC Test market is a subset of the larger Diagnostics market, which is composed of a variety of tests used to diagnose and monitor diseases. The Diagnostics market is expected to grow in the coming years due to advances in technology and the increasing prevalence of chronic diseases. Some companies in the TIBC Test market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, and Beckman Coulter. Show Less Read more